Jeffrey Adam Novack sold $91k of CDNA
Secretary and General Counsel at CareDx, Inc.. 4,441 shares at an average of $20.56, traded Feb 3, 2026, filed Feb 4, 2026.
Score components
- +15RoleOfficer
- +9Trade size$91k at market
- 0Share of holdings soldSold 3.4% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -5.5%, 3m +10.7%, 6m +140.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002019976-26-000001, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 2, 2026 | AGrant or award Common Stock | +33,000 | $0.00 | $0 | 130,925 | Feb 4, 2026 |
| Feb 2, 2026 | AGrant or award Common Stock | +4,342 | $0.00 | $0 | 135,267 | Feb 4, 2026 |
| Feb 2, 2026 | FTax withholding Common Stock | -2,492 | $20.42 | $51k | 132,775 | Feb 4, 2026 |
| Feb 2, 2026 | FTax withholding Common Stock | -2,970 | $20.42 | $61k | 129,805 | Feb 4, 2026 |
| Feb 3, 2026 | SOpen-market sale Common Stock10b5-1 | -4,441 | $20.56 | $91k | 125,364 | Feb 4, 2026 |
Related signals
Other insiders at CareDx, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 59Moderate | CareDx, Inc. | George Bickerstaff director | $926k 20,000 shares | -13% | |
| 42Moderate | CareDx, Inc. | Christine Cournoyer director | $751k 16,000 shares | -27% | |
| 65Notable | CareDx, Inc. | Michael Goldberg director | $2.1M 44,700 shares | -42% | |
| 20Weak | CareDx, Inc. | Jeffrey Adam Novack Secretary and General Counsel | $124k 2,688 shares | -2% | |
| 28Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $4.5M 118,000 shares | -15% | |
| 23Weak | CareDx, Inc. | Hannah Valantine director | $1.0M 28,779 shares | -44% | |
| 23Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $1.2M 40,000 shares | -6% | |
| 29Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $425k 17,683 shares | -3% | |
| 22Weak | CareDx, Inc. | Hannah Valantine director | $280k 12,103 shares | -25% | |
| 31Weak | CareDx, Inc. | John Walter Hanna JR President and CEO | $528k 21,998 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.